I see your point for patients in the TNBC trial, but why would emergency patients? To me that is even more of a reason....by the time they qualify for expanded access the last thing they probably want to do is a weekly trip to the doctor/clinic. That is one of the huge benefits of lero being sub-q so it can be self administered and improve QOL.

You obviously know the clinical and medical side of things much better than me. I’m just trying to apply common sense based on some insight from NPs comment.